Docetaxel/trastuzumab combination therapy for the treatment of breast cancer

By Nabholtz Jean-marc   Gligorov Joseph  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 9, 2005-08 ,pp. : 1555-1564

Informa Healthcare

Access to resources Recommend Favorite

Docetaxel: a new active agent in the therapy of metastatic breast cancer

By Fumoleau P.   Seidman A.D.   Trudeau M.E.   Chevallier B.   Huinink W.W.T.B.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 12, 1997-12 ,pp. : 1853-1866

Informa Healthcare

Access to resources Recommend Favorite

Economic evaluation of docetaxel for breast cancer

By Lwin Zarnie   Leighl Natasha  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 2, 2009-02 ,pp. : 283-290

Informa Healthcare

Access to resources Recommend Favorite

Paclitaxel and docetaxel in the treatment of breast cancer

By Saloustros Emmanouel   Mavroudis Dimitris   Georgoulias Vassilis  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 15, 2008-10 ,pp. : 2603-2616

Informa Healthcare

Access to resources Recommend Favorite

Neoadjuvant docetaxel, vinorelbine and trastuzumab prior to surgery and adjuvant therapy is active in patients with HER-2 breast cancer

By  

Inpharma, Vol. 1, Iss. 1579, 2007-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite